Table of Contents Author Guidelines Submit a Manuscript
International Journal of Endocrinology
Volume 2013, Article ID 167138, 7 pages
http://dx.doi.org/10.1155/2013/167138
Review Article

Osteoporosis Associated with Antipsychotic Treatment in Schizophrenia

1Institute of Mental Health, Second Xiangya Hospital, Central South University, Changsha 410011, China
2Department of Nursing, Second Xiangya Hospital, Central South University, Changsha 410011, China

Received 19 December 2012; Revised 20 February 2013; Accepted 18 March 2013

Academic Editor: Guang-Da Xiang

Copyright © 2013 Haishan Wu et al. This is an open access article distributed under the Creative Commons Attribution License, which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited.

Citations to this Article [16 citations]

The following is the list of published articles that have cited the current article.

  • Tiziana Caciari, Maria Valeria Rosati, Valeria Di Giorgio, Teodorico Casale, Benedetta Pimpinella, Barbara Scala, Roberto Giubilati, Assunta Capozzella, Gianfranco Tomei, and Francesco Tomei, “Urinary nickel and prolactin in workers exposed to urban stressors,” Environmental Science: Processes & Impacts, vol. 15, no. 11, pp. 2096, 2013. View at Publisher · View at Google Scholar
  • B. Stubbs, M. De Hert, A. A. Sepehry, C. U. Correll, A. J. Mitchell, A. Soundy, J. Detraux, and D. Vancampfort, “A meta-analysis of prevalence estimates and moderators of low bone mass in people with schizophrenia,” Acta Psychiatrica Scandinavica, 2014. View at Publisher · View at Google Scholar
  • Hui Tang, Jingping Zhao, Ying Wu, Yi Yang, Haishan Wu, Beibei Zhang, and Jindong Chen, “Insight into the physiopathologic mechanism for the coexistence of depression and osteoporosis,” Current Signal Transduction Therapy, vol. 10, no. 1, pp. 4–9, 2015. View at Publisher · View at Google Scholar
  • Christoph U. Correll, Johan Detraux, Jan De Lepeleire, and Marc De Hert, “Effects of antipsychotics, antidepressants and mood stabilizers on risk for physical diseases in people with schizophrenia, depression and bipolar disorder,” World Psychiatry, vol. 14, no. 2, pp. 119–136, 2015. View at Publisher · View at Google Scholar
  • Zahra Zamani, Samad Zare, Rajabali Sadrkhanlou, Abbas Ahmadi, and Elham Movahed, “Chlorpromazine-induced hyperprolactinemia on rat’s uterus,” Iranian Biomedical Journal, vol. 19, no. 4, pp. 226–232, 2015. View at Publisher · View at Google Scholar
  • Donna Ames, Sian M. Carr-Lopez, Mary A. Gutierrez, Joseph M. Pierre, Jennifer A. Rosen, Susan Shakib, and Lynn M. Yudofsky, “Detecting and Managing Adverse Effects of Antipsychotic Medications,” Psychiatric Clinics of North America, 2016. View at Publisher · View at Google Scholar
  • Rohit J. Lodhi, Salaj Masand, Amna Malik, Kuppuswami Shivakumar, Victoria D.M. McAllister, Veronica O'Keane, Leah C. Young, Adrian H. Heald, Roy A. Sherwood, and Katherine J. Aitchison, “Changes in biomarkers of bone turnover in an aripiprazole add-on or switching study,” Schizophrenia Research, 2016. View at Publisher · View at Google Scholar
  • Marc De Hert, Johan Detraux, and Brendon Stubbs, “Relationship between antipsychotic medication, serum prolactin levels and osteoporosis/osteoporotic fractures in patients with schizophrenia: a critic,” Expert Opinion On Drug Safety, vol. 15, no. 6, pp. 809–823, 2016. View at Publisher · View at Google Scholar
  • Jingyi Cui, Huaqing Liu, Jing Shao, Dong-Mei Xu, Yi Wang, Zheng Fei, Jiyu Wei, Wei Lu, Chun-Rong Wang, Rui He, Yangya Tan, Yi Fan, Yuping Ning, Ryan M. Cassidy, Jair C. Soares, Xingbing Huang, and Xiang Yang Zhang, “Prevalence, risk factors and clinical characteristics of osteoporosis in Chinese inpatients with schizophrenia,” Schizophrenia Research, 2017. View at Publisher · View at Google Scholar
  • Chiara Colletti, Walter Milano, and Anna Capasso, “Hyperprolactinemia induced by antipsychotics: From diagnosis to treatment approach,” Endocrine, Metabolic and Immune Disorders - Drug Targets, vol. 17, no. 1, pp. 38–55, 2017. View at Publisher · View at Google Scholar
  • Gricel Paulina Orellana Vidal, Matías Rodríguez, Nicolás González, and Eduardo Durán, “The association of schizophrenia with chronic non transmissible diseases,” Revista Medica de Chile, vol. 145, no. 8, pp. 1047–1053, 2017. View at Publisher · View at Google Scholar
  • Sumeet Gupta, Udayan Khastgir, Dev A. M. Lakshmanan, and Rajesh Nair, “Management of antipsychotic-induced hyperprolactinaemia,” BJ Psych Advances, vol. 23, no. 4, pp. 278–286, 2017. View at Publisher · View at Google Scholar
  • Jing Huang, Danwei Zhao, Zhixiong Liu, and Fangkun Liu, “Repurposing psychiatric drugs as anti-cancer agents,” Cancer Letters, vol. 419, pp. 257–265, 2018. View at Publisher · View at Google Scholar
  • Naomi Mehta, Shahed Imrit, Julie Thorp, Chris Ince, Thomas Lewis, and Iain McKinnon, “Vitamin D in patients with intellectual and developmental disability in secure in-patient services in the North of England, UK,” Psychiatrist, vol. 42, no. 1, pp. 24–29, 2018. View at Publisher · View at Google Scholar
  • Daniel Kopf, and Walter Hewer, “Somatische Risiken bei alt gewordenen Menschen mit schweren psychiatrischen Erkrankungen,” Zeitschrift für Gerontologie und Geriatrie, 2018. View at Publisher · View at Google Scholar
  • Min Jhon, Taeyoung Yoo, Ju-Yeon Lee, Seon-Young Kim, Jae-Min Kim, Il-Seon Shin, Lana Williams, Michael Berk, Jin-Sang Yoon, and Sung-Wan Kim, “Gender-specific risk factors for low bone mineral density in patients taking antipsychotics for psychosis,” Human Psychopharmacology: Clinical and Experimental, pp. e2648, 2018. View at Publisher · View at Google Scholar